Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Supriya Arora

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Medicine|March 11, 2023
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous ChorioretinopathySonny Caplash, Thamolwan Surakiatchanukul, Supriya Arora, et al.
European Journal of Ophthalmology|November 8, 2021
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysisSupriya Arora, Dmitrii S Maltsev, Sumit Singh Randhir, et al.
Vaccine|September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trialGlenn Hamonic, Elodie Pastural, Supriya Arora, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Clinical Medicine|March 11, 2023
Multimodal Imaging Based Predictors for the Development of Choroidal Neovascularization in Patients with Central Serous ChorioretinopathySonny Caplash, Thamolwan Surakiatchanukul, Supriya Arora, et al.
European Journal of Ophthalmology|November 8, 2021
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysisSupriya Arora, Dmitrii S Maltsev, Sumit Singh Randhir, et al.
Vaccine|September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trialGlenn Hamonic, Elodie Pastural, Supriya Arora, et al.
Pageof 6